Abu Dhabi-listed Gulf Pharmaceutical Industries (Julphar) on Wednesday said its Dh500 million rights issue was more than two times oversubscribed, totalling Dh1.14 billion. The net proceeds of the rights issue, which closed on July 12, will be used to implement its growth plans, repay existing loans, and sustain its working capital needs. The rights issue was priced at Dh1 per share. Its shares on Wednesday fell 4.6 per cent to ...